E. Pyott David - 29 Jun 2021 Form 4/A - Amendment Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Director
Signature
/s/ Mike Ouimette, attorney-in-fact
Issuer symbol
PLRX
Transactions as of
29 Jun 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
01 Jul 2021, 20:14
Date Of Original Report
30 Jun 2021
Previous filing
27 May 2021
Next filing
19 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (right to buy) Award $0 +13.3K $0.00 13.3K 29 Jun 2021 Common Stock 13.3K $28.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter following June 29, 2021 for three calendar quarters and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of June 29, 2021 or (ii) the next annual meeting of the stockholders, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting.

Remarks:

This amendment is being filed solely to correct the expiration date previously reported for this option grant. All other information in the original Form 4 remains the same.